Weiss Amir 4

What Happened
Amir Weiss, Chief Accounting Officer of Teva Pharmaceutical Industries Ltd (TEVA), disposed of 10,679 ordinary shares in an open-market sale on May 6, 2026. The shares were sold at $36.00 per share for a total transaction value of $384,444. This filing reports a sale (S) rather than a purchase.

Key Details

• Transaction date: 2026-05-06; reported on Form 4 filed 2026-05-07 (timely filing).
• Price and quantity: 10,679 shares sold at $36.00 per share; total proceeds $384,444.
• Shares owned after transaction: Not disclosed in this Form 4.
• Transaction type: Open-market sale (code S).
• Footnote: F1 notes ordinary shares may be represented by American Depositary Shares (each ADS currently represents one ordinary share).
• Filing timeliness: Appears timely (filed the day after the reported transaction).

Context
Sales by company insiders are common and may be for personal liquidity, tax, or diversification reasons; they do not by themselves indicate a change in company fundamentals. Purchases generally carry more weight for signaling insider confidence. This report documents a straightforward open-market sale with no derivatives, gifting, or option-exercise activity disclosed.